TP53 and breast cancer: Kadouri et al. reviewed 473 BRCA and p53 mutation carriers and found the rate of RIS to be 0.43% (n = seven women), but the overall rate is still low and not significantly different compared to all breast cancer patients with RISs reported in other studies [21].